Utah Medical Products (NASDAQ:UTMD) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

Utah Medical Products, Inc. (NASDAQ:UTMD)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $61.15 and traded as high as $65.68. Utah Medical Products shares last traded at $65.42, with a volume of 6,799 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, February 25th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, Utah Medical Products presently has a consensus rating of “Hold”.

Utah Medical Products Trading Up 0.6%

The company has a 50-day moving average of $65.56 and a 200-day moving average of $61.15. The firm has a market capitalization of $208.04 million, a price-to-earnings ratio of 19.36 and a beta of 0.35.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.17%. The firm had revenue of $8.72 million during the quarter.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 3rd. Stockholders of record on Tuesday, March 17th were issued a $0.31 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $1.24 annualized dividend and a dividend yield of 1.9%. Utah Medical Products’s payout ratio is 36.69%.

Institutional Investors Weigh In On Utah Medical Products

A number of institutional investors have recently modified their holdings of the business. Segall Bryant & Hamill LLC bought a new position in Utah Medical Products in the third quarter worth about $726,000. Everett Harris & Co. CA boosted its stake in Utah Medical Products by 24.1% in the fourth quarter. Everett Harris & Co. CA now owns 21,344 shares of the medical instruments supplier’s stock valued at $1,194,000 after acquiring an additional 4,151 shares during the period. Minerva Advisors LLC grew its holdings in shares of Utah Medical Products by 0.6% during the fourth quarter. Minerva Advisors LLC now owns 93,615 shares of the medical instruments supplier’s stock valued at $5,239,000 after purchasing an additional 557 shares during the last quarter. LSV Asset Management grew its holdings in shares of Utah Medical Products by 3.9% during the fourth quarter. LSV Asset Management now owns 13,474 shares of the medical instruments supplier’s stock valued at $754,000 after purchasing an additional 500 shares during the last quarter. Finally, Cardinal Capital Management raised its position in shares of Utah Medical Products by 1.9% during the 4th quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier’s stock worth $1,394,000 after purchasing an additional 459 shares during the period. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).